ProCE Banner Activity

Severe Hypertriglyceridemia: Causes, Current Treatments, and Emerging Therapies

Clinical Thought

Read my take on how to approach the diagnosis and treatment of severe hypertriglyceridemia, including emerging agents.

Released: February 01, 2024

Share

Faculty

Michael Miller

Michael Miller, MD, FACC, FAHA

Cardiologist & Professor of Medicine
Hospital of the University of Pennsylvania
Chief of Medicine
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Michael Miller, MD, FACC, FAHA

Cardiologist & Professor of Medicine
Hospital of the University of Pennsylvania
Chief of Medicine
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Michael Miller, MD: consultant/advisor/speaker: Amarin, Ionis, 89Bio.